RNase H-dependent DNA thresholder modulated by cancer marker concentration

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• Antisense oligonucleotides (ASOs) are short nucleic acid sequences targeting specific mRNA molecules.
• Gene expression levels, particularly oncogene expression, can differ significantly between cancerous and normal cells.
• Developing precise methods for gene silencing and cell differentiation is crucial in cancer research.

Purpose of the Study:

• To design and evaluate threshold antisense oligonucleotide constructs capable of cleaving mRNA at specific biomarker concentrations.
• To investigate the potential of these constructs in differentiating cancer cells from normal cells based on oncogene expression levels.
• To enable targeted gene silencing in cancer cells.

Main Methods:

• Design of threshold antisense oligonucleotide constructs with varying activation thresholds.
• Testing mRNA cleavage efficiency at different biomarker concentrations (2.6, 7.5, and 39.5 nM).
• Assessing the constructs' ability to differentiate cell types based on oncogene expression and subsequent gene silencing.

Main Results:

• mRNA cleavage was successfully activated by specific biomarker concentrations (2.6, 7.5, or 39.5 nM) depending on construct design.
• The constructs demonstrated the ability to respond to different levels of biomarker concentration, indicating tunable activation.
• Successful differentiation of cell types based on oncogene expression levels was achieved, leading to targeted gene silencing.

Conclusions:

• Threshold antisense oligonucleotide constructs provide a tunable platform for targeted mRNA cleavage and gene silencing.
• These constructs can effectively differentiate cancer cells from normal cells by exploiting differences in oncogene expression.
• This technology holds promise for developing novel diagnostic and therapeutic strategies in oncology.